Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients

NCT00336895 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00336895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00336895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2006
Completion date
November 30, 2008
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression